Instruction for use: Sachol

Active substance Choline salicylate

ATX Code S02DA Analgesics and Anesthetics

Pharmacological groups

NSAIDs - Salicylic Acid Derivatives

Nosological classification (ICD-10)

J11 Influenza, virus not identified

Flu, Influenza in the early stages of the disease, Flu in children, cold in the chest, Begins flu-like condition, Acute disease parainfluenza, parainfluenza, parainfluenza state, influenza epidemics, The pains of the flu, Influenza

M79.0 Other unspecified rheumatism

Degenerative rheumatic disease, Degenerative and rheumatic diseases of the tendons, Degenerative rheumatic diseases, Localized forms of rheumatism of soft tissues, Rheumatism, Rheumatism with a pronounced allergic component, Rheumatism of the articular and extraarticular, Rheumatic attack, Rheumatic complaints, Rheumatic diseases, Rheumatic disease of the spine, Relapses of rheumatism, Articular and extra-articular rheumatism, Articular and muscular rheumatism, Articular rheumatism, Articular syndrome with rheumatism, Chronic rheumatic pain, Chronic articular rheumatism, Rheumatoid diseases, Rheumatic diseases of the intervertebral disc

M79.1 Myalgia

Myofascial pain syndromes ,Pain syndrome in musculo-articular diseases, Pain syndrome in chronic inflammatory diseases of the musculoskeletal system, Pain in the muscles, Tenderness of muscles, Muscular soreness in severe physical exertion, Painful conditions of the musculoskeletal system, Pain in the musculoskeletal system, Pain in the muscles, Pain at rest, Muscle aches, Muscle pain, Musculoskeletal pain, Myalgia, Muscle pain, Muscle pain at rest, Muscle pain, Muscular pain of non-rheumatic origin, Muscle pain of rheumatic origin, Acute muscle pain, Rheumatic pain, Rheumatic pains, Myofascial syndrome, Fibromyalgia

M79.2 Neurology and neuritis, unspecified

Pain syndrome with neuralgia, Brachialgia, Occipital and intercostal neuralgia, Neuralgia, Neuralgic pain, Neuralgia, Neuralgia of intercostal nerves,Neuralgia of the posterior tibial nerve, Neuritis, Neuritis traumatic, Neuritis, Neurological Pain Syndromes, Neurological contractures with spasms, Acute neuritis, Peripheral neuritis,Post-traumatic neuralgia,Severe pain of a neurogenic nature, Chronic neuritis, Essential neuralgia

R50 Fever of unknown origin

Malignant hyperthermia, Hyperthermia malignant

Composition and form of release

1 ml of syrup contains choline salicylate 128 mg, which corresponds to 100 mg of acetylsalicylic acid; in bottles of 150 ml.

pharmachologic effect

Pharmacological action - anti-inflammatory, antipyretic, analgesic.

It inhibits cyclooxygenase and inhibits the biosynthesis of PG (prostaglandins).

Indication

Fever, cold and rheumatic diseases, neuralgia, myalgia.

Contraindications

Hypersensitivity, peptic ulcer of the stomach and duodenum in the acute stage, bronchial asthma, pollinosis, hemorrhagic diathesis.

Side effects

Pain in the abdomen, nausea, exacerbation of peptic ulcer of the stomach and duodenum, lesions of the gastric mucosa, dizziness, impaired renal function, erythropenia, leukopenia, thrombocytopenia, nosebleeds, allergic skin reactions.

Dosing and Administration

Inside, adults and children over 12 years of age - 640-960 mg (5-7.5 ml) 4-6 times a day; children: 2-3 years - 0.5-1.5 ml, 4-7 years - 2 ml, 8-12 years - 3 ml 4 times a day.

Precautionary measures

Use with caution during pregnancy and lactation (at the time of admission should refrain from breastfeeding), not recommended for children under 1 year.

storage Conditions

In dry, the dark place at room temperature.

Keep out of the reach of children.

Shelf life

3 years.

Do not use after the expiry date printed on the package.